|
Market Closed -
Bombay S.E.
13:02:30 13/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 28.50 INR | -4.49% |
|
-0.25% | -40.20% |
| Market Cap | 1.01B 10.66M 9.66M 8.94M 8.06M 15.19M 15.73M 107M 42.56M 537M 40M 39.16M 1.7B | P/E 2025 |
-22.5x | P/E 2026 | -8.33x |
|---|---|---|---|---|---|
| Enterprise Value | 1.27B 13.46M 12.2M 11.28M 10.18M 19.18M 19.86M 136M 53.74M 678M 50.51M 49.44M 2.15B | EV / Sales 2025 |
14.5x | EV / Sales 2026 | 4.45x |
| Free-Float |
25.69% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | -4.49% | ||
| 1 week | -0.25% | ||
| Current month | +2.81% | ||
| 1 month | -5.38% | ||
| 3 months | -14.77% | ||
| 6 months | -6.95% | ||
| Current year | -40.20% |
| 1 week | 28.1 |  | 31.5 |
| 1 month | 27 | | 32.5 |
| Current year | 25.6 | | 50.9 |
| 1 year | 25.6 | | 53.9 |
| 3 years | 25.6 | | 87.46 |
| 5 years | 10.17 | | 87.46 |
| 10 years | 2.15 | | 87.46 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 13/10/2022 | |
| Chief Tech/Sci/R&D Officer | - | 07/08/2025 | |
| Compliance Officer | - | 14/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 05/12/2025 | |
| Director/Board Member | - | 29/08/2023 | |
| Chairman | 51 | 31/01/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.49% | -0.25% | -35.83% | -33.61% | 10.66M | |
| +1.26% | +6.61% | +40.79% | +136.32% | 1,286B | |
| +0.79% | +3.45% | +45.84% | +93.52% | 688B | |
| +0.20% | +1.28% | +26.97% | +113.70% | 521B | |
| -0.44% | +3.69% | +41.45% | +68.91% | 386B | |
| +0.55% | +0.70% | +59.02% | +44.62% | 364B | |
| -0.12% | +0.74% | +28.39% | +58.54% | 302B | |
| +0.37% | +0.37% | +3.33% | +37.27% | 287B | |
| -0.30% | +1.14% | +38.29% | +72.46% | 252B | |
| +0.08% | +0.71% | +34.44% | +124.95% | 208B | |
| Average | -0.21% | +1.84% | +28.27% | +71.67% | 429B | |
| Weighted average by Cap. | +0.54% | +3.26% | +37.70% | +96.50% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 194M 2.06M 1.87M 1.73M 1.56M 2.94M 3.04M 20.77M 8.23M 104M 7.74M 7.58M 330M | 279M 2.96M 2.68M 2.48M 2.24M 4.21M 4.36M 29.77M 11.81M 149M 11.1M 10.86M 473M |
| Net income | -108M -1.14M -1.04M -958K -864K -1.63M -1.69M -11.51M -4.56M -57.57M -4.29M -4.2M -183M | -117M -1.24M -1.13M -1.04M -940K -1.77M -1.83M -12.51M -4.96M -62.59M -4.66M -4.56M -199M |
| Net Debt | 399M 4.23M 3.83M 3.55M 3.2M 6.03M 6.24M 42.59M 16.89M 213M 15.87M 15.54M 676M | 264M 2.8M 2.54M 2.35M 2.12M 3.99M 4.13M 28.2M 11.18M 141M 10.51M 10.29M 448M |
Employees
127
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/11/26 | ₹28.50 | -4.49% | 4,022 |
| 12/11/26 | ₹29.84 | +2.30% | 3,966 |
| 11/11/26 | ₹29.17 | -2.77% | 21,227 |
| 09/11/26 | ₹30.00 | 0.00% | 21,174 |
| 08/11/26 | ₹30.00 | +5.01% | 807 |
- Stock Market
- Stocks
- PHARMAID Stock
Select your edition
All financial news and data tailored to specific country editions
